Issued Patents All Time
Showing 25 most recent of 67 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12258309 | Ultra short acting anti-arrhythmic agents | John Somberg | 2025-03-25 |
| 11731938 | Ultra short acting anti-arrhythmic agents | John Somberg | 2023-08-22 |
| 11286235 | Ultra short acting anti-arrhythmic agents | John Somberg | 2022-03-29 |
| 11179370 | Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers | John F. McElroy | 2021-11-23 |
| 10793519 | Ultra short acting anti-arrhythmic agents | John Somberg | 2020-10-06 |
| 10617673 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2020-04-14 |
| 9987253 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2018-06-05 |
| 9517228 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2016-12-13 |
| 9133127 | Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers | John F. McElroy | 2015-09-15 |
| 8853252 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2014-10-07 |
| 8716265 | 4-quinolinemethanols as anti-malarial agents | John F. McElroy, David Nugiel | 2014-05-06 |
| 8680131 | Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers | John F. McElroy | 2014-03-25 |
| 8648072 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2014-02-11 |
| 8580768 | Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2013-11-12 |
| 8541475 | MAO-B inhibitors useful for treating obesity | John F. McElroy, Parthasarathi Rajagopalan | 2013-09-24 |
| 8334282 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2012-12-18 |
| 8252791 | Purine compounds as cannabinoid receptor blockers | John F. McElroy | 2012-08-28 |
| 8236821 | Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity | John F. McElroy | 2012-08-07 |
| 8217038 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2012-07-10 |
| 8138216 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2012-03-20 |
| 8138209 | Substituted picolinamides as MAO-B inhibitors useful for treating obesity | John F. McElroy, Rajagopalan Parthasarathi | 2012-03-20 |
| 8133904 | Cannabinoid receptor antagonists/inverse agonists useful for treating obesity | John F. McElroy | 2012-03-13 |
| 8124802 | MAO inhibiting N-benzyl-N-propargyl-amines useful for treating obesity | John F. McElroy | 2012-02-28 |
| 8088926 | Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity | John F. McElroy | 2012-01-03 |
| 8088809 | Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes | John F. McElroy | 2012-01-03 |